Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Pi Health to Collaborate with GSK to Enhance Clinical Research Services
07:45am, Wednesday, 24'th Sep 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pi Health, a global health technology and clinical research company, today announced it will provide fully outsourced clinical research services in a GSK clinical tr
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 23'rd Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GSK to submit label update for Leucovorin at FDA's request, does not intend to market it for autism
06:20pm, Monday, 22'nd Sep 2025
CNBC's Angelica Peebles joins 'Fast Money' with breaking news on GSK and its drug Leucovorin.
FDA approves drug that Trump due to suggest as autism treatment
04:55pm, Monday, 22'nd Sep 2025
The U.S. Food and Drug Administration announced approval of leucovorin, a form of folic acid that U.S. President Donald Trump was slated to suggest as a treatment for autism symptoms at a White House
Here's Why GSK (GSK) is a Strong Growth Stock
10:46am, Monday, 22'nd Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years
01:01pm, Wednesday, 17'th Sep 2025
GSK commits $30B to U.S. R&D and manufacturing, with advanced AI-driven biopharma facilities set to expand jobs and innovation.
GSK commits $30bn to US drug research and manufacturing
03:11am, Wednesday, 17'th Sep 2025
GSK PLC (LSE:GSK, NYSE:GSK) will pour $30 billion into research, development and manufacturing in the United States over the next five years, in one of the largest overseas investment programmes anno
UK's GSK announces $30 billion U.S. pharma investment amid Trump state visit
02:29am, Wednesday, 17'th Sep 2025
British pharmaceutical giant GSK committed to investing at least $30 billion in U.S. research and developing and manufacturing over the next five years.
GSK and Eli Lilly are the latest to unveil plans to add to manufacturing and increase other operations in America.
GSK plans $30 billion US investment as pharma tariff threat looms
07:08pm, Tuesday, 16'th Sep 2025
GSK said on Wednesday it plans to invest $30 billion in research and development and supply chain infrastructure in the United States over the next five years, after U.S. President Donald Trump arrive
GSK Says It Will Spend $30B on U.S. Manufacturing and R&D
07:01pm, Tuesday, 16'th Sep 2025
The U.K.-based firm and other drugmakers are seeking to avoid tariffs on drugs imported into the U.S.
Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon?
12:15pm, Tuesday, 16'th Sep 2025
GSK faces U.S. vaccine sales declines as Shingrix and Arexvy stumble. Penmenvy approval and pipeline efforts may aid long-term growth.
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?
01:28pm, Wednesday, 03'rd Sep 2025
Wave Life Sciences Ltd. WVE stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSK
10:00am, Wednesday, 03'rd Sep 2025
NEW YORK , Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE: GSK).
GSK Adds Around $5B in a Month: Here's How to Play the Stock
10:51am, Tuesday, 02'nd Sep 2025
GSK stock adds nearly $5B in value in a month as Specialty Medicines growth, pipeline wins and a strong outlook outweigh vaccine headwinds.
